Results 81 to 90 of about 4,441,858 (304)
Performances of the optimized RF models with MOE and IE descriptors on the training set (cross-validation CV) and the external validation set.
Elodie Goldwaser (12004103) +9 more
core +1 more source
Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta +3 more
wiley +1 more source
Cohort design of the external validation of the PAR Risk Score.
Cohort design of the external validation of the PAR Risk Score.
Lukas Higi (11747618) +6 more
core +1 more source
Structure‐forward targeting of claudins with synthetic binders
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley +1 more source
External validation cohort—TBI severity and time to blood draw.
External validation cohort—TBI severity and time to blood draw.
Jeffrey Bazarian (5125661) +8 more
core +1 more source
Comparison of derivation and validation datasets (internal and external).b'*'
Comparison of derivation and validation datasets (internal and external).b'*'
Katherine Fielding (168885) +21 more
core +1 more source
PurposeTo develop and externally validate a pragmatic and interpretable model that predicts infection risk in chronic nonhealing wounds using routine electronic medical record data.MethodsWe conducted a two-center retrospective study at two tertiary ...
Yang Jiang +6 more
doaj +1 more source
Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang +2 more
wiley +1 more source
UMAP projection of external validation set for VGG-20 experiment.
UMAP projection of external validation set for VGG-20 experiment.
Marco Chierici (5055626) +8 more
core +1 more source
Objective: Low-dose Synacthen stimulation test (LDSST) is widely used to assess central adrenal insufficiency (CAI). With the adoption of monoclonal antibody (mAb) cortisol immunoassays, lower basal and peak cortisol concentration thresholds require ...
Buşra Gürpınar Tosun +5 more
doaj +1 more source

